Bioventus Senior Management to Present at Upcoming Investor Conferences

Rhea-AI Summary

Bioventus (Nasdaq: BVS) announced its participation in two upcoming virtual conferences: the Canaccord Genuity Virtual Musculoskeletal Conference on May 20 at 8:30 a.m. ET and the Goldman Sachs 42nd Annual Global Healthcare Conference on June 9 at 11:20 a.m. ET. Presentation materials will be accessible on the investor relations section of the Bioventus website prior to each event. A live audio webcast and replay links will also be available for 30 days afterward. Bioventus focuses on innovations for active healing, particularly in osteoarthritis and various pain management solutions.

DURHAM, N.C., May 17, 2021 (GLOBE NEWSWIRE) -- Senior management of Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, will present at the Canaccord Genuity Virtual Musculoskeletal Conference on Thursday, May 20 at 8:30 a.m. ET and the Goldman Sachs 42nd Annual Global Healthcare Conference on Wednesday, June 9 at 11:20 a.m. ET. Both events are virtual conferences.

Presentation materials from the events will be available in the investor relations section on the Bioventus website at https://www.bioventus.com prior to the start of each presentation. In addition, a live audio webcast of the Company’s presentation at each event will be available under the investor relations section of the Bioventus website and links to a replay of these events may be accessed via the investor relations section for at least 30 days.

About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for osteoarthritis, surgical and non-surgical bone healing. With the recent acquisition of Bioness, Inc., Bioventus expanded product offerings now include products for acute and chronic pain, central nervous system disorders including stroke and orthopedic injuries. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, www.bioness.com and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Media Contact:
Thomas Hill
919-474-6715
thomas.hill@bioventus.com

Investor Inquiries:
Mike Piccinino, CFA, IRC
Westwicke/ICR
investor.relations@bioventus.com

FAQ

When will Bioventus present at the Canaccord Genuity Virtual Musculoskeletal Conference?

Bioventus will present at the Canaccord Genuity Virtual Musculoskeletal Conference on May 20, 2021, at 8:30 a.m. ET.

What time is Bioventus's presentation at the Goldman Sachs Healthcare Conference?

The presentation by Bioventus at the Goldman Sachs 42nd Annual Global Healthcare Conference will take place on June 9, 2021, at 11:20 a.m. ET.

Where can I find Bioventus's presentation materials for the upcoming conferences?

Presentation materials for Bioventus's conferences will be available in the investor relations section of their website before each event.

Will there be a live audio webcast for Bioventus's conference presentations?

Yes, a live audio webcast of Bioventus's presentations will be available on their investor relations website during the events.

How long will the replays of Bioventus's conference presentations be available?

Replays of Bioventus's conference presentations will be accessible for at least 30 days on their investor relations section.